These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 33408337)
1. New insights into the treatment of CTD-ILD. Wells AU Nat Rev Rheumatol; 2021 Feb; 17(2):79-80. PubMed ID: 33408337 [No Abstract] [Full Text] [Related]
2. Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and Opportunities. Fischer A; Strek ME; Cottin V; Dellaripa PF; Bernstein EJ; Brown KK; Danoff SK; Distler O; Hirani N; Jones KD; Khanna D; Lee JS; Lynch DA; Maher TM; Millar AB; Raghu G; Silver RM; Steen VD; Volkmann ER; Mullan RH; O'Dwyer DN; Donnelly SC Arthritis Rheumatol; 2019 Feb; 71(2):182-195. PubMed ID: 30604506 [No Abstract] [Full Text] [Related]
3. An analysis of connective tissue disease-associated interstitial lung disease at a US Tertiary Care Center: better survival in patients with systemic sclerosis. Su R; Bennett M; Jacobs S; Hunter T; Bailey C; Krishnan E; Rosen G; Chung L J Rheumatol; 2011 Apr; 38(4):693-701. PubMed ID: 21285162 [TBL] [Abstract][Full Text] [Related]
4. Comparing the safety and efficacy of nintedanib starting dose in patients with connective tissue disease-associated interstitial lung diseases. Ayano M; Tsubouchi K; Suzuki K; Kimoto Y; Arinobu Y; Akashi K; Horiuchi T; Okamoto I; Niiro H Scand J Rheumatol; 2024 Jul; 53(4):255-262. PubMed ID: 38563202 [TBL] [Abstract][Full Text] [Related]
10. Treatment of connective tissue disease-associated interstitial lung disease: the pulmonologist's point of view. Koo SM; Uh ST Korean J Intern Med; 2017 Jul; 32(4):600-610. PubMed ID: 28704913 [TBL] [Abstract][Full Text] [Related]
11. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ? de Lauretis A; Veeraraghavan S; Renzoni E Chron Respir Dis; 2011; 8(1):53-82. PubMed ID: 21339375 [TBL] [Abstract][Full Text] [Related]
12. Overview of Rheumatoid Arthritis-Associated Interstitial Lung Disease and Its Treatment. Pugashetti JV; Lee JS Semin Respir Crit Care Med; 2024 Jun; 45(3):329-341. PubMed ID: 38484788 [TBL] [Abstract][Full Text] [Related]
13. Chest CT imaging features for prediction of treatment response in cryptogenic and connective tissue disease-related organizing pneumonia. Cho YH; Chae EJ; Song JW; Do KH; Jang SJ Eur Radiol; 2020 May; 30(5):2722-2730. PubMed ID: 32040727 [TBL] [Abstract][Full Text] [Related]
14. Rheumatoid arthritis-associated interstitial lung disease: an overview of epidemiology, pathogenesis and management. Dai Y; Wang W; Yu Y; Hu S Clin Rheumatol; 2021 Apr; 40(4):1211-1220. PubMed ID: 32794076 [TBL] [Abstract][Full Text] [Related]
15. Rheumatoid arthritis-related interstitial lung disease (RA-ILD): methotrexate and the severity of lung disease are associated to prognosis. Rojas-Serrano J; Herrera-Bringas D; Pérez-Román DI; Pérez-Dorame R; Mateos-Toledo H; Mejía M Clin Rheumatol; 2017 Jul; 36(7):1493-1500. PubMed ID: 28585060 [TBL] [Abstract][Full Text] [Related]
16. Demographic and clinical predictors of progression and mortality in connective tissue disease-associated interstitial lung disease: a retrospective cohort study. Chan C; Ryerson CJ; Dunne JV; Wilcox PG BMC Pulm Med; 2019 Oct; 19(1):192. PubMed ID: 31672127 [TBL] [Abstract][Full Text] [Related]
17. Interstitial lung disease related to rheumatoid arthritis: evolution after treatment. Rojas-Serrano J; González-Velásquez E; Mejía M; Sánchez-Rodríguez A; Carrillo G Reumatol Clin; 2012; 8(2):68-71. PubMed ID: 22341526 [TBL] [Abstract][Full Text] [Related]